West Nile virus: Characterization and diagnostic applications of monoclonal antibodies

Virology Journal

Volumn 9, Issue , 2012, Pages

  Lelli, Davide ^a   Moreno, Ana ^a   Brocchi, Emiliana ^a   Sozzi, Enrica ^a   Capucci, Lorenzo ^a   Canelli, Elena ^a   Barbieri, Ilaria ^a   Zeller, Herve ^a   Cordioli, Paolo ^a  

^a ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL EMILIA ROMAGNA   (Italy)

Author keywords

Epitope; Monoclonal antibody; West Nile virus

Indexed keywords

ENVELOPE PROTEIN; GLUTAMIC ACID; ISOLEUCINE; LYSINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1C3; MONOCLONAL ANTIBODY 2A8; MONOCLONAL ANTIBODY 3B2; MONOCLONAL ANTIBODY 3D6; MONOCLONAL ANTIBODY 4D3; MONOCLONAL ANTIBODY 4G9; NEUTRALIZING ANTIBODY; SERINE; THREONINE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; VIRUS ANTIBODY;

AMINO ACID SUBSTITUTION; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BINDING COMPETITION; CHICKEN; CONTROLLED STUDY; CROSS REACTION; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FLAVIVIRUS; GENE MUTATION; HORSE; IMMUNOGENICITY; JAPANESE ENCEPHALITIS VIRUS; MOUSE; MUTANT; NONHUMAN; PROTEIN DOMAIN; SEQUENCE ANALYSIS; SERODIAGNOSIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; USUTU FLAVIVIRUS; VIRUS GENE; VIRUS INFECTION; VIRUS NEUTRALIZATION; WEST NILE FLAVIVIRUS; WESTERN BLOTTING; YELLOW FEVER FLAVIVIRUS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DIAGNOSTIC PROCEDURE; EVALUATION; HUMAN; IMMUNOASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; SENSITIVITY AND SPECIFICITY; VIROLOGY; WEST NILE FEVER;

EQUIDAE; USUTU VIRUS; WEST NILE VIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CHICKENS; CLINICAL LABORATORY TECHNIQUES; CROSS REACTIONS; EPITOPE MAPPING; EQUIDAE; HUMANS; IMMUNOASSAY; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; SENSITIVITY AND SPECIFICITY; VIROLOGY; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84859632012     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-81     Document Type: Article

References (38)

1. Transmission dynamics and changing epidemiology of West Nile virus. Blitvich BJ, Anim Health Res Rev 2008 9 71 86 10.1017/S1466252307001430 18348742
2. The molecular biology of West Nile Virus: a new invader of the western hemisphere. Brinton MA, Annu Rev Microbiol 2002 56 371 402 10.1146/annurev. micro.56.012302.160654 12142476 (Pubitemid 35217460)
3. Structure of dengue virus: implicationsfor flavivirus organization, maturation, and fusion. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH, Cell 2002 108 717 725 10.1016/S0092-8674(02)00660-8 11893341 (Pubitemid 34241430)
4. Structure of the dengue virus envelope protein after membrane fusion. Modis Y, Ogata S, Clements D, Harrison SC, Nature 2004 427 6972 313 319 10.1038/nature02165 14737159 (Pubitemid 38133652)
5. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC, Nature 1995 375 291 298 10.1038/375291a0 7753193
6. Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. Kanai R, Kar K, Anthony K, Gould LH, Ledizet M, Fikrig E, Marasco WA, Koski RA, Modis Y, J Virol 2006 80 11000 11008 10.1128/JVI.01735-06 16943291 (Pubitemid 44706541)
7. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. Beasley DW, Barrett ADT, J Virol 2002 76 13097 13100 10.1128/JVI.76.24.13097-13100.2002 12438639 (Pubitemid 35386997)
8. Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans. Ludolfs D, Niedrig M, Paweska LT, Schmitz H, Eur J Clin Microbiol Infect Dis 2007 26 467 473 10.1007/s10096-007-0309-1 17554572 (Pubitemid 47025033)
9. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nybakken GE, Oliphant T, Johnson S, Burke S, Diamond MS, Fremont DH, Nature 2005 437 764 769 10.1038/nature03956 16193056 (Pubitemid 41486548)
10. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, Ebel GD, Kramer LD, Fremont DH, Diamond MS, Nat Med 2005 11 522 530 10.1038/nm1240 15852016 (Pubitemid 40685975)
11. Characterization of neutralizing antibodies to West Nile virus. Sánchez MD, Pierson TC, McAllister D, Hanna SL, Puffer BA, Valentine LE, Murtadha MM, Hoxie JA, Doms RW, Virology 2005 336 70 82 10.1016/j.virol.2005.02. 020 15866072 (Pubitemid 40603672)
12. Ongoing outbtreak of West Nile virus infections in humans in Greece. Papa A, Danis K, Baka A, Bakas A, Dougas G, Lytras T, Theocharapoulos G, Chrysagis D, Vassiliadou E, Kamaria F, Liona A, Mellou K, Saroglou G, Panagiotopoulos T, Euro Surveill 2010 15 34 ii:19644
13. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, Brandt WE, J Gen Virol 1989 70 37 43 10.1099/0022-1317-70-1-37 2543738 (Pubitemid 19045417)
14. Evidence of simultaneous circulation of West Nile and Usutu viruses in mosquitoes sampled in Emilia-Romagna region (Italy) in 2009. Calzolari M, Bonilauri P, Bellini R, Albieri A, Defilippo F, Maioli G, Galletti G, Gelati A, Barbieri I, Tamba M, Lelli D, Carra E, Cordioli P, Angelini P, Dottori M, PLoS One 2010 5 12 14324 10.1371/journal.pone.0014324 21179462
15. Detection of Usutu virus within a West Nile virus surveillance program in Northern Italy. Tamba M, Bonilauri P, Bellini R, Calzolari M, Albieri A, Sambri V, Dottori M, Angelini P, Vector Borne Zoonotic Dis 2010 11 551 557 20849275
16. West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. Chambers TJ, Halevy M, Nestorowicz A, Rice CM, Lustig S, J Gen Virol 1998 79 2375 2380 9780042 (Pubitemid 28464294)
17. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. Throsby M, Geuijen C, Goudsmit J, Bakker AQ, Korimbocus J, Kramer RA, Clijsters-Van der Horst C, De Jong M, Jongeneelen M, Thijsse S, Smit R, Visser TJ, Bijl N, Marissen WE, Loeb M, Kelvin DJ, Preiser W, Ter Meulen J, DE Kruif J, J Virol 2006 80 6982 6992 10.1128/JVI.00551-06 16809304 (Pubitemid 44025197)
18. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. Chávez JH, Silva JR, Amarilla AR, Biologicals 2010 38 6 613 618 10.1016/j.biologicals.2010.07.004 20817489
19. Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. Beasley D, Holbrook M, Travassos Da Rosa A, Coffey L, Carrara A, Bohm RP, Phillippi-Falkenstein K, Ratterree MS, Lillibridge KM, Ludwig GV, Estrada-Franco J, Weaver SC, Tesh RB, Shope RE, Barrett ADT, J Clin Microbiol 2004 42 2759 2765 10.1128/JCM.42.6.2759- 2765.2004 15184463 (Pubitemid 38747532)
20. Use of recombinant E protein domain IIIbased enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses. Holbrook M, Shope R, Barrett A, J Clin Microbiol 2004 42 4101 4110 10.1128/JCM.42.9.4101-4110.2004 15364996 (Pubitemid 39296130)
21. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. Chu J, Chiang C, Ng M, J Immunol 2007 178 2699 26705 17312111
22. Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice. Alka, Bharati K, Malik Y, Vrati S, Med Microbiol Immunol 2007 196 227 231 10.1007/s00430-007- 0043-4 17377815 (Pubitemid 350105922)
23. A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity. Leng C, Liu S, Tsai J, Li Y, Chen M, Liu H, Lien S, Yueh A, Hsiao K, Lai L, Liu F, Chong P, Chen H, Microbes Infect 2009 11 288e95
24. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes Dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the Dengue type 2 virus envelope glycoprotein. Goncalvez AP, Purcell RH, Lai CJ, J Virol 2004 78 12919 129128 10.1128/JVI.78.23.12919-12928.2004 15542644 (Pubitemid 39507800)
25. Protective and Therapeutic Capacity of Human Single-Chain Fv-Fc Fusion Proteins against West Nile Virus. Gould LH, Foellmer JH, Oliphant T, Wang T, Ledizet M, Murakami A, Noonan K, Lambeth K, Kar K, Anderson JF, De Silva AM, Diamond MS, Koski RA, Marasco WA, Fikrig E, J Virol 2005 79 14606 14613 10.1128/JVI.79.23.14606-14613.2005 16282460 (Pubitemid 41636259)
26. Neutralizing monoclonal antibodies against Russian strain of the West Nile virus. Razumov IA, Kazachinskaia EI, Ternovoi VA, Protopopova EV, Galkina IV, Gromashevskii VL, Prilipov AG, Kachko AV, Ivanova AV, L'vov DK, Loktev VB, Viral Immunol 2005 18 558 568 10.1089/vim.2005.18.558 16212535
27. Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein. Oliphant T, Nybakken GE, Engle M, Xu Q, Nelson CA, Sukupolvi-Petty S, Marri A, Lachmi BE, Olshevsky U, Fremont DH, Pierson TC, Diamond MS, J Virol 2006 80 12149 12159 10.1128/JVI.01732-06 17035317 (Pubitemid 44904366)
28. Murray valley encephalitis virus envelope protein antigenic variants with altered Hemagglutination properties and reduced Neuroinvasiveness in Mice. Mcminn PC, Lee E, Hartley S, Roehrig JT, Dalgarno L, Weir C, Virol 1995 211 10 20 10.1006/viro.1995.1374
29. The neutralizing antibody response against West Nile virus in naturally infected horses. Sánchez MD, Pierson TC, Degrace MM, Mattei LM, Hanna SL, Del Piero F, Doms RW, Virology 2007 59 336 348 (Pubitemid 46290659)
30. Characterization and application of monoclonal antibodies specific to West Nile virus envelope protein. Liu J, Liu B, Cao Z, Inoue S, Morita K, Tian K, Zhu Q, Gao GF, J Virol Methods 2008 154 20 26 10.1016/j.jviromet.2008.09.019 18948139
31. Preparation of monoclonal antibodies, strategies and procedure. Galfre G, Milstein C, Methods Enzymol 1981 73 3 5 7300683
32. Harlow E, Lane D, Antibodies A Laboratory Manual New York: Cold Spring Harbor Laboratory Press 1988 469
33. Highly efficient and simple methods for the preparation of peroxidase and active peroxidase-antibodies conjugates for enzyme immunoassays. Tjissen P, Kurstak E, Analyt Biochem 1984 136 451 457 10.1016/0003-2697(84)90243-4 6372541
34. Detection and preliminary characterization of a new rabbit calicivirus related to hemorrhagic disease virus but nonpathogenic. Capucci L, Fusi, Lavazza A, Pacciarini ML, Rossi C, J Virol 1996 70 8614 8623 8970986 (Pubitemid 26378441)
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Laemmli UK, Nature 1970 227 680 685 10.1038/227680a0 5432063
36. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Towbin H, Staehelin T, Gordon J, Biotchnology 1992 24 145 149
37. Characterization of antigenic variants of tick-borne encephalitis virus selected with neutralizing monoclonal antibodies. Holzmann H, Mandl CW, Guirakhoo F, Heinz FX, Kunz C, J Gen Virol 1989 70 219 222 10.1099/0022-1317-70- 1-219 2471781 (Pubitemid 19045425)
38. Jourdain E, Oiseaux savages et virus West Nile: étude éco-épidémiologique en Camarge PhD thesis Grenoble: Universidad de Joseph Fourier 1995